Patent · US Active

Anthranilic acid derivatives and their use in the treatment of human cancers

US11905268B2 · kind B2 · utility

0Cited by
4References
4Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 12, 2019
Grant dateFeb 20, 2024
Priority date
Expiry dateAug 12, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D409/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Various embodiments relate to compounds and methods useful for preventing or treating a cancer in a subject. The method may include administering to a subject a composition according to any of the embodiments described herein in an amount effective to inhibit metastatic activity or tumor growth in the subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.